Guillard, Olivier, Fauconneau, Bernard, Pineau, Alain et al. · Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) · 2012 · DOI
This case report describes a woman who developed a small lump under her skin at a vaccine injection site years after vaccination. Researchers tested the tissue and found very high levels of aluminum compared to control samples. The study suggests that aluminum from vaccine adjuvants might accumulate in the body and potentially cause long-term problems like chronic fatigue syndrome.
For ME/CFS patients and researchers investigating potential environmental triggers, this study contributes to the growing body of evidence examining whether vaccine adjuvants—particularly aluminum compounds—might play a role in post-vaccination illness pathogenesis. Understanding aluminum bioaccumulation mechanisms could inform both patient management and vaccine safety monitoring protocols.
This single case report does not establish causation between aluminum accumulation and ME/CFS or other chronic conditions; it only documents elevated aluminum levels in one patient with pseudolymphoma. The study cannot determine whether aluminum exposure caused the tissue lesion or chronic symptoms, or whether similar accumulation occurs in asymptomatic vaccinated individuals. No data on symptom onset timing relative to vaccination or aluminum deposition is provided.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →